Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Consensus Rating of Buy from Brokerages

Mind Medicine (MindMed) Inc. (NASDAQ:MNMD – Get Free Report) has been assigned a consensus rating of “Buy” from the eight brokerages that are currently covering the firm, Marketbeat reports. Eight equities research analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have issued a report on […]

Related Keywords

Canada ,Schondl Greenway ,Robert Barrow ,Jpmorgan Chase Co ,Nasdaq ,Royal Bank ,Renaissance Technologies ,Freestone Capital Holdings ,Medicine Mindmed Inc ,Star Investment Management Corp ,Cantor Fitzgerald ,Mind Medicine ,Get Free Report ,Star Investment Management ,Capital Holdings ,Get Free ,Mind Medicine Mindmed ,Nasdaq Mnmd ,Mnmd ,Medical ,Ratings ,Consensus ,